Jump to content

David Joyner (business executive)

Add links
From Wikipedia, the free encyclopedia

David Joyner
Born1964 (age 61–62)
Alma materTexas Tech University (BBA)
TitleCEO, CVS Health
Term2024–present
PredecessorKaren S. Lynch
SpouseCarrie Joyner
Websitecvshealth.com

J. David Joyner (born 1964) is an American business executive. He is the president and chief executive officer (CEO) of CVS Health, and the former president of CVS Caremark.

Personal life

[edit]

Joyner earned a Bachelor of Business Administration in finance from Texas Tech University in 1986.[1] There, he became a member of the Phi Delta Theta fraternity.[2][3]

He is a partial owner of the Lubbock Matadors SC, a men's soccer club based in Lubbock, Texas.[4]

Career

[edit]

He first worked at Aetna as an employee benefit representative before joining CVS Caremark as a regional sales manager for Caremark Prescription Services. He then became executive vice president before eventually becoming president of the company.[1] He briefly left CVS in 2020 and returned to run Caremark in 2023.[5] He is on the advisory council of the Rawls College of Business.[1]

In October 2024, Joyner became the president and chief executive officer of CVS Health, along with joining the board of directors.[6][7][8][9] He replaced Karen S. Lynch.[10] Reuters reported that Joyner was appointed after pressure from investors over low company share price.[7] In November 2025, CVS Health appointed Joyner chair of the board.[11]

Joyner was named on Modern Healthcare's 100 Most Influential People in Healthcare 2025 list.[12]

2024 Congressional testimony

[edit]

In July 2024, he testified before the United States House Committee on Oversight and Accountability about pharmacy benefit managers and prescription drug markets.[13] Representative James Comer (R–KY) threatened leaders of the three largest pharmacy benefit managers with steep fines or jail time for allegedly lying in a previous hearing.[14] In response, Joyner declined to change his testimony.[15][16]

References

[edit]
  1. ^ a b c "David Joyner". Rawls College of Business Texas Tech University. Archived from the original on December 6, 2024. Retrieved December 6, 2024.
  2. ^ "The Phi Delta Theta Foundation 2020 Annual Report". Isuu. Phi Delta Theta. August 30, 2021. p. 53. Retrieved December 7, 2024.
  3. ^ "David Joyner". Phi Delta Theta. Retrieved January 21, 2026.
  4. ^ "OWNERSHIP — Lubbock Matadors SC". December 7, 2024. Retrieved December 8, 2024.{{cite web}}: CS1 maint: deprecated archival service (link)
  5. ^ "CVS Names New Leaders for Pharmacy Services, Consumer Products". Bloomberg.com. January 23, 2023. Retrieved December 6, 2024.
  6. ^ Tulfo, Erika (October 18, 2024). "CVS names new CEO in the wake of layoffs and poor stock performance". cnn.com. CNN. Retrieved October 20, 2024.
  7. ^ a b Roy, Sriparna; Leo, Leroy (October 19, 2024). "CVS names Joyner as CEO under investor pressure, withdraws profit forecast". Reuters. Retrieved December 6, 2024.
  8. ^ "CVS Health CEO Karen Lynch steps down, replaced by David Joyner, after 19% stock plunge". cbsnews.com. CBS News. October 18, 2024. Retrieved October 20, 2024.
  9. ^ Constantino, Annika Kim; Pramuk, Jacob (October 18, 2024). "CVS replaces CEO Karen Lynch with exec David Joyner as profits, share price suffer". CNBC. Retrieved December 6, 2024.
  10. ^ Lavin, Nancy (October 18, 2024). "CVS Health is hurting. Will a new CEO cure its financial ills?". Retrieved December 6, 2024.
  11. ^ "CVS Health consolidates power under CEO David Joyner with new chairman role". Providence Business First. November 21, 2025. Retrieved January 21, 2026.
  12. ^ "David Joyner: 100 Most Influential People in Healthcare 2025 - Modern Healthcare". www.modernhealthcare.com. Retrieved January 21, 2026.
  13. ^ Comer, James (August 28, 2024). "Letter to Joyner FINAL re PBM Hearing Testimony" (PDF). United States House of Representatives Committee on Oversight and Accountability. Retrieved December 7, 2024.
  14. ^ Pifer, Rebecca (August 29, 2024). "PBM executives threatened with fines and jail time for alleged perjury in House hearing". Healthcare Dive. Retrieved December 6, 2024.
  15. ^ Pifer, Rebecca (September 12, 2024). "PBM executives decline to revise controversial testimony to House committee". Healthcare Dive. Retrieved December 6, 2024.
  16. ^ Armstrong, Drew (September 11, 2024). "CVS says it won't correct congressional testimony". Endpoints News. Retrieved December 6, 2024.(subscription required)
[edit]


Stub icon

This article about a chief executive from the United States is a stub. You can help Wikipedia by adding missing information.

Retrieved from "https://en.wikipedia.org/w/index.php?title=David_Joyner_(business_executive)&oldid=1334164814"